We are sterile contract manufacturers

HollisterStier Company Background
   Founded: 1921
   Location: Spokane, Washington
   Focus: Parenteral Contract Manufacturing and Sterile Contract Manufacturing
   Facility: 191,000 ft² CBER and CDER registered
   Ownership: Jubilant Life Sciences, Ltd.
   Employees: 550

Click here to view the capabilities of HollisterStier and our sister organizations.

HollisterStier Contract Manufacturing is a global manufacturing service provider, able to aseptically fill liquid and lyophilized products at our Spokane, Washington facility and semi-solid and solid dosage forms at our sister organizations located in Canada, the United States and India.

Highly skilled, cross-functional teams provide custom solutions to customer-specific project goals from development through commercialization. HollisterStier is designed for multi-product operations and houses four separate manufacturing areas that include two commercial high speed fill lines and clinical trial and small lot manufacturing areas.

HollisterStier offers multiple options for compounding including aseptic compounding, portable compounding vessels and large fixed compounding tanks. The vial and packaging inspection areas include visual inspection, labeling, Ink Jet coding and secondary packaging.

Onsite, HollisterStier offers a full-service 6,000ft² laboratory that includes quality analytical testing services with an analytical chemistry department that is staffed by highly-trained, credentialed technicians and scientists. Microbiological support services are also provided.

HollisterStier is owned by Jubilant Life Sciences, Ltd., one of the largest custom research and manufacturing services (CRAMS) and drug discovery and development services companies in India. Our sister organization, DRAXIS Pharma, is also owned by Jubilant and is aligned with HollisterStier to provide expanded capabilities and services to our clients.

Clinical through Commercial Manufacturing

HollisterStier has the unique capability to accommodate products in all stages of development. Manufacturing can occur in one of four different areas:

Small Volume Parenterals Areas (SVP I and II)
Phase I through Commercial
Lot Sizes up to 375,000 vials/day
Liquid or Lyophilized products

Clinical Trial and Small Lot Manufacturing Areas

Clinical Trial
Phase I through Commercial
Lot sizes up to 5,000 vials/day

Small Lot Manufacturing (SLM)
Phase I through Commercial
Lot sizes up to 10,000 vials/day
Liquid or Lyophilized products

HollisterStier has experience with the following types of products:

• Vaccines
• Biological Proteins
• Microspheres
• Liposomes
• Suspensions
• WFI/Diluents
• Lyophilized products

HollisterStier does not manufacture penicillin or penicillin-containing products, cephalosporins, live bacterial or live viral vaccines.